1. Home
  2. BMRN vs STN Comparison

BMRN vs STN Comparison

Compare BMRN & STN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$53.06

Market Cap

10.5B

Sector

Health Care

ML Signal

HOLD

Logo Stantec Inc

STN

Stantec Inc

HOLD

Current Price

$93.59

Market Cap

11.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMRN
STN
Founded
1996
1954
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.5B
11.3B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
BMRN
STN
Price
$53.06
$93.59
Analyst Decision
Buy
Analyst Count
19
0
Target Price
$88.42
N/A
AVG Volume (30 Days)
2.9M
229.3K
Earning Date
10-27-2025
11-13-2025
Dividend Yield
N/A
0.67%
EPS Growth
59.53
44.12
EPS
2.68
3.04
Revenue
$3,094,001,000.00
$4,547,020,941.00
Revenue This Year
$13.39
$12.18
Revenue Next Year
$7.57
$10.03
P/E Ratio
$19.89
$30.72
Revenue Growth
12.39
12.49
52 Week Low
$50.76
$73.18
52 Week High
$73.51
$114.52

Technical Indicators

Market Signals
Indicator
BMRN
STN
Relative Strength Index (RSI) 46.21 31.22
Support Level $52.55 $94.41
Resistance Level $54.33 $96.21
Average True Range (ATR) 1.24 1.46
MACD -0.17 0.34
Stochastic Oscillator 19.23 17.44

Price Performance

Historical Comparison
BMRN
STN

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.

Share on Social Networks: